363. A Phase II Prospective Randomized Study to Assess Imipenem-Relebactam in the Management of Cancer Patients with Febrile Neutropenia

BACKGROUND: The overuse of antibiotics has led to the emergence of antibiotic resistance that poses a significant threat particularly for the immunocompromised cancer patients. Hence, the empiric therapy with standard antibiotic could be suboptimal in these vulnerable patients who often receive anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaftari, Anne-Marie, Dagher, Hiba, Hachem, Ray Y, Jiang, Ying, Lamie, Peter, Dib, Rita Wilson, John, Teny, Haddad, Andrea, Philip, Ann, Ali, Shahnoor, Mulanovich, Patricia, Juan, Ying, Chaftari, Patrick, Raad, Issam I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676838/
http://dx.doi.org/10.1093/ofid/ofad500.433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676838/
http://dx.doi.org/10.1093/ofid/ofad500.433

Ejemplares similares